{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-26-007090","form_type":"8-K","ticker":"SBFM","cik":"0001402328","company_name":"Sunshine Biopharma Inc.","filed_at":"2026-09-11T21:00:14+00:00","discovered_at":"2026-09-11T21:02:00.313030+00:00","generated_at":"2026-09-11T21:02:09.860680+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Sunshine Biopharma cuts Series B warrant exercise price to $1.2046","bullets":["As of September 11, 2026, Sunshine Biopharma reduced its Series B Warrant exercise price to $1.2046.","Reduction stems from recent common-stock sales under the company's at-the-market offering.","The exercise price remains subject to further adjustment per Series B Warrant terms."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-26-007090","json":"https://secwatch.observer/filing/0001683168-26-007090.json","markdown":"https://secwatch.observer/filing/0001683168-26-007090.md","text":"https://secwatch.observer/filing/0001683168-26-007090.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007090/0001683168-26-007090-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402328/000168316826007090/sunshine_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T21:02:09.860680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}